Market Tracker

02/21 2:05pm ET

Cascadian Therapeutics Inc (NASDAQ:CASC)

4.29
Delayed Data
As of 1:50pm ET
 -0.04 / -0.92%
Today’s Change
3.49
Today|||52-Week Range
10.98
-0.46%
Year-to-Date
No recent news for Cascadian Therapeutics Inc.

Today’s Trading

Previous close4.33
Today’s open4.38
Day’s range4.25 - 4.40
Volume110,389
Average volume (3 months)251,266
Market cap$198.0M
Dividend yield--
Data as of 1:50pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)+46.88%
Earnings growth (this year)-61.76%
Earnings growth (next 5 years)+0.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.91

Competitors

 Today’s
change
Today’s
% change
AVXLAnavex Life Sciences...+0.05+0.95%
CDXSCodexis Inc-0.05-1.23%
ARWRArrowhead Pharmaceut...-0.00-0.23%
BCLIBrainstorm Cell Ther...+0.10+2.78%
Data as of 2:01pm ET, 02/21/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.52
Annual revenue (last year)$0.00
Annual profit (last year)-$32.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott D. Myers
Chief Operating Officer
Gary W. Christianson
Corporate headquarters
Seattle, Washington

Forecasts